Boxer Capital Management, LLC Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$332.5B
Holdings
28
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (28 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | RVMDREVOLUTION MEDICINES INC | 1,317,977 | $46.6B | 14.02% | |
| 2 | NUVLNUVALENT INC | 450,000 | $31.9B | 9.60% | |
| 3 | MRUSMERUS N V | 700,000 | $29.5B | 8.86% | |
| 4 | RNAAVIDITY BIOSCIENCES INC | 865,000 | $25.5B | 7.68% | |
| 5 | ANABANAPTYSBIO INC | 1,300,000 | $24.2B | 7.27% | |
| 6 | XENEXENON PHARMACEUTICALS INC | 600,000 | $20.1B | 6.05% | |
| 7 | REPLREPLIMUNE GROUP INC | 1,796,341 | $17.5B | 5.27% | |
| 8 | APLSAPELLIS PHARMACEUTICALS INC | 713,000 | $15.6B | 4.69% | |
| 9 | CMRXEURCHIMERIX INC | 1,810,000 | $15.4B | 4.63% | |
| 10 | TNGXTANGO THERAPEUTICS INC | 10,380,999 | $14.2B | 4.28% | |
| 11 | ELVNENLIVEN THERAPEUTICS INC | 671,358 | $13.2B | 3.97% | |
| 12 | ORICORIC PHARMACEUTICALS INC | 1,732,571 | $9.7B | 2.91% | |
| 13 | DAWNDAY ONE BIOPHARMACEUTICALS I | 1,189,943 | $9.4B | 2.84% | |
| 14 | KYMRKYMERA THERAPEUTICS INC | 325,000 | $8.9B | 2.68% | |
| 15 | PRTAPROTHENA CORP PLC | 690,000 | $8.5B | 2.57% | |
| 16 | QUREUNIQURE NV | 750,000 | $8.0B | 2.39% | |
| 17 | LEGNLEGEND BIOTECH CORP | 200,000 | $6.8B | 2.04% | |
| 18 | NRIXNURIX THERAPEUTICS INC | 563,067 | $6.7B | 2.01% | |
| 19 | AMLXAMYLYX PHARMACEUTICALS INC | 1,750,000 | $6.2B | 1.86% | |
| 20 | SLDBSOLID BIOSCIENCES INC | 1,240,700 | $4.6B | 1.38% | |
| 21 | DNLIDENALI THERAPEUTICS INC | 250,000 | $3.4B | 1.02% | |
| 22 | KODKODIAK SCIENCES INC | 1,035,000 | $2.9B | 0.87% | |
| 23 | PRLDPRELUDE THERAPEUTICS INC | 2,108,014 | $1.6B | 0.49% | |
| 24 | TILINSTIL BIO INC | 80,125 | $1.4B | 0.42% | |
| 25 | BOLDBOUNDLESS BIO INC | 250,000 | $377.5M | 0.11% | |
| 26 | CLYMCLIMB BIO INC | 145,000 | $176.9M | 0.05% | |
| 27 | NUVB/WSNUVATION BIO INC | 266,666 | $85.3M | 0.03% | |
| 28 | SRZNWSURROZEN INC | 66,666 | $2.0M | 0.00% |